Sight Sciences (SGHT) Common Equity (2020 - 2025)
Historic Common Equity for Sight Sciences (SGHT) over the last 6 years, with Q3 2025 value amounting to $64.3 million.
- Sight Sciences' Common Equity fell 3229.57% to $64.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.3 million, marking a year-over-year decrease of 3229.57%. This contributed to the annual value of $87.5 million for FY2024, which is 2719.46% down from last year.
- As of Q3 2025, Sight Sciences' Common Equity stood at $64.3 million, which was down 3229.57% from $70.0 million recorded in Q2 2025.
- In the past 5 years, Sight Sciences' Common Equity registered a high of $246.0 million during Q3 2021, and its lowest value of -$117.3 million during Q2 2021.
- For the 5-year period, Sight Sciences' Common Equity averaged around $124.0 million, with its median value being $123.6 million (2023).
- As far as peak fluctuations go, Sight Sciences' Common Equity surged by 36123.76% in 2021, and later crashed by 3229.57% in 2025.
- Quarter analysis of 5 years shows Sight Sciences' Common Equity stood at $232.1 million in 2021, then tumbled by 31.03% to $160.1 million in 2022, then dropped by 24.9% to $120.2 million in 2023, then decreased by 27.19% to $87.5 million in 2024, then decreased by 26.55% to $64.3 million in 2025.
- Its last three reported values are $64.3 million in Q3 2025, $70.0 million for Q2 2025, and $77.6 million during Q1 2025.